Selection and education of patients for inhaled insulin

Srikanth Bellary, Anthony H. Barnett

Research output: Contribution to journalArticlepeer-review


Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.
Original languageEnglish
Pages (from-to)363-368
Number of pages6
JournalCurrent Diabetes Reports
Issue number5
Publication statusPublished - 1 Oct 2007


  • inhalation administration
  • oral administration
  • type 1 diabetes mellitus
  • type 2 diabetes mellitus
  • smoking
  • hypoglycemic agents
  • insulin
  • respiratory function tests
  • patient selection


Dive into the research topics of 'Selection and education of patients for inhaled insulin'. Together they form a unique fingerprint.

Cite this